M. Zivkov

785 total citations
14 papers, 582 citations indexed

About

M. Zivkov is a scholar working on Pharmacology, Psychiatry and Mental health and Biological Psychiatry. According to data from OpenAlex, M. Zivkov has authored 14 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 11 papers in Psychiatry and Mental health and 2 papers in Biological Psychiatry. Recurrent topics in M. Zivkov's work include Treatment of Major Depression (11 papers), Bipolar Disorder and Treatment (7 papers) and Electroconvulsive Therapy Studies (5 papers). M. Zivkov is often cited by papers focused on Treatment of Major Depression (11 papers), Bipolar Disorder and Treatment (7 papers) and Electroconvulsive Therapy Studies (5 papers). M. Zivkov collaborates with scholars based in United States, Netherlands and Austria. M. Zivkov's co-authors include Kees van Heeringen, Paul‐Egbert Reimitz, Stuart Montgomery, Richard S.E. Keefe, Stephen R. Marder, Robert W. Buchanan, J. M. A. Sitsen, Nina R. Schooler, Michelle Stewart and A. Dugar and has published in prestigious journals such as The British Journal of Psychiatry, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

M. Zivkov

14 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Zivkov United States 10 367 303 75 73 71 14 582
R. Tamura United States 8 865 2.4× 236 0.8× 42 0.6× 15 0.2× 73 1.0× 30 1.1k
Gordon F. Johnson Australia 14 432 1.2× 124 0.4× 136 1.8× 14 0.2× 33 0.5× 31 797
Ayako Kaneda Japan 15 167 0.5× 80 0.3× 42 0.6× 32 0.4× 56 0.8× 42 533
Arash Mowla Iran 14 195 0.5× 121 0.4× 73 1.0× 39 0.5× 106 1.5× 35 617
Nadia R. Kunz United States 9 224 0.6× 248 0.8× 29 0.4× 43 0.6× 34 0.5× 18 730
P. J. Perry United States 12 526 1.4× 216 0.7× 89 1.2× 9 0.1× 138 1.9× 20 872
Doron Mazeh Israel 16 326 0.9× 89 0.3× 56 0.7× 22 0.3× 26 0.4× 21 544
Peiling Yang United States 9 137 0.4× 220 0.7× 61 0.8× 26 0.4× 25 0.4× 15 452
Alma Mihaljević Peleš Croatia 15 222 0.6× 77 0.3× 153 2.0× 50 0.7× 91 1.3× 26 575

Countries citing papers authored by M. Zivkov

Since Specialization
Citations

This map shows the geographic impact of M. Zivkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Zivkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Zivkov more than expected).

Fields of papers citing papers by M. Zivkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Zivkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Zivkov. The network helps show where M. Zivkov may publish in the future.

Co-authorship network of co-authors of M. Zivkov

This figure shows the co-authorship network connecting the top 25 collaborators of M. Zivkov. A scholar is included among the top collaborators of M. Zivkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Zivkov. M. Zivkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Keefe, Richard S.E., Robert W. Buchanan, Stephen R. Marder, et al.. (2012). Poster #199 CLINICAL TRIALS OF POTENTIAL COGNITIVE-ENHANCING DRUGS IN SCHIZOPHRENIA: WHAT HAVE WE LEARNED SO FAR?. Schizophrenia Research. 136. S352–S352. 1 indexed citations
2.
Keefe, Richard S.E., Robert W. Buchanan, Stephen R. Marder, et al.. (2011). Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?. Schizophrenia Bulletin. 39(2). 417–435. 114 indexed citations
3.
Kremer, C.M.E., et al.. (1998). Mirtazapine vs fluoxetine: Efficacy on symptoms associated with depression. European Psychiatry. 13(S4). 265s–265s. 1 indexed citations
4.
Montgomery, Stuart, Paul‐Egbert Reimitz, & M. Zivkov. (1998). Mirtazapine versus amitriptyline in the long-term treatment of depression. International Clinical Psychopharmacology. 13(2). 63–74. 90 indexed citations
5.
Stahl, Stephen M., M. Zivkov, Paul‐Egbert Reimitz, John Panagides, & William G. van’t Hoff. (1997). Meta‐analysis of randomized, double‐blind, dacebo‐controlled, efficacy and safety studies of mirtazapine versus amitripcyline in major depression. Acta Psychiatrica Scandinavica. 96(s391). 22–30. 32 indexed citations
6.
Kasper, Siegfried, et al.. (1997). Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline. European Neuropsychopharmacology. 7(2). 115–124. 25 indexed citations
7.
Heeringen, Kees van & M. Zivkov. (1996). Pharmacological Treatment of Depression in Cancer Patients. The British Journal of Psychiatry. 169(4). 440–443. 116 indexed citations
8.
Zivkov, M., et al.. (1996). Safety of mirtazapine in overdose. European Neuropsychopharmacology. 6. S4–62. 2 indexed citations
9.
Klint, Thorsten, et al.. (1996). Lack of typical SSRI-related adverse effects and sexual dysfunction with mirtazapine is related to specific blockade of 5-HT2 and 5-HT3 receptors. European Neuropsychopharmacology. 6. S4–61. 1 indexed citations
10.
Marttila, M., et al.. (1995). A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression. European Neuropsychopharmacology. 5(4). 441–446. 47 indexed citations
11.
Sitsen, J. M. A. & M. Zivkov. (1995). Mirtazapine. CNS Drugs. 4(Supplement 1). 39–48. 31 indexed citations
12.
Zivkov, M., et al.. (1995). Org 3770 versus amitriptyline: A 6‐week randomized double‐blind multicentre trial in hospitalized depressed patients. Human Psychopharmacology Clinical and Experimental. 10(3). 173–180. 49 indexed citations
13.
Zivkov, M., et al.. (1995). Efficacy of Org 3770 (mirtazapine) vs amitriptyline in patients with major depressive disorder: A meta-analysis. Human Psychopharmacology Clinical and Experimental. 10(S2). S135–S145. 20 indexed citations
14.
Delisle, J., et al.. (1995). A multicentre, double‐blind, clomipramine‐controlled efficacy and safety study of org 3770. Human Psychopharmacology Clinical and Experimental. 10(4). 263–271. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Tamura Breakdown of academic impact, for papers by Gordon F. Johnson Breakdown of academic impact, for papers by Ayako Kaneda Breakdown of academic impact, for papers by Arash Mowla Breakdown of academic impact, for papers by Nadia R. Kunz Breakdown of academic impact, for papers by P. J. Perry Breakdown of academic impact, for papers by Doron Mazeh Breakdown of academic impact, for papers by Peiling Yang Breakdown of academic impact, for papers by Alma Mihaljević Peleš
Rankless by CCL
2026